Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kumar-Singh, S.
Right arrow Articles by Van Broeckhoven, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar-Singh, S.
Right arrow Articles by Van Broeckhoven, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 18 2589-2598
© 2000 Oxford University Press

Nonfibrillar diffuse amyloid deposition due to a {gamma}42-secretase site mutation points to an essential role for N-truncated Aß42 in Alzheimer’s disease

Samir Kumar-Singh, Chris De Jonghe, Marc Cruts, Reinhold Kleinert1, Rong Wang2, Marc Mercken3, Bart De Strooper4, Hugo Vanderstichele5, Ann Löfgren, Inge Vanderhoeven, Hubert Backhovens, Eugeen Vanmechelen5, Peter M. Kroisel6 and Christine Van Broeckhoven+

Laboratory of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, Universiteitsplein 1, B-2610, Antwerpen, Belgium, 1Laboratory of Neuropathology, Institute of Pathology and 6Laboratory of Human Genetics, Institute for Medical Biology and Human Genetics, University of Graz, Austria, 2Laboratory for Mass Spectrometry, The Rockefeller University, NY, USA, 3Janssen Research Foundation, Beerse, Belgium, 4Laboratory of Neuronal Cell Biology and Gene Transfer, University of Leuven and 5Innogenetics, Zwijnaarde, Belgium

Amyloidogenic processing of the amyloid precursor protein (APP) with deposition in brain of the 42 amino acid long amyloid ß-peptide (Aß42) is considered central to Alzheimer’s disease (AD) pathology. However, it is generally believed that nonfibrillar pre-amyloid Aß42 deposits have to mature in the presence of Aß40 into fibrillar amyloid plaques to cause neurodegeneration. Here, we describe an aggressive form of AD caused by a novel missense mutation in APP (T714I) directly involving {gamma}-secretase cleavages of APP. The mutation had the most drastic effect on Aß42/Aß40 ratio in vitro of ~11-fold, simultaneously increasing Aß42 and decreasing Aß40 secretion, as measured by matrix-assisted laser disorption ionization time-of-flight mass spectrometry. This coincided in brain with deposition of abundant and predominant nonfibrillar pre-amyloid plaques composed primarily of N-truncated Aß42 in complete absence of Aß40. These data indicate that N-truncated Aß42 as diffuse nonfibrillar plaques has an essential but undermined role in AD pathology. Importantly, inhibiting secretion of full-length Aß42 by therapeutic targeting of APP processing should not result in secretion of an equally toxic N-truncated Aß42.

+ To whom correspondence should be addressed. Tel: +32 3 820 2601; Fax:+32 3 820 2541; Email: cvbroeck@uia.ua.ac.be


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch NeurolHome page
B. J. Snider, J. Norton, M. A. Coats, S. Chakraverty, C. E. Hou, R. Jervis, C. L. Lendon, A. M. Goate, D. W. McKeel Jr, and J. C. Morris
Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life
Arch Neurol, December 1, 2005; 62(12): 1821 - 1830.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Kumar-Singh, D. Pirici, E. McGowan, S. Serneels, C. Ceuterick, J. Hardy, K. Duff, D. Dickson, and C. Van Broeckhoven
Dense-Core Plaques in Tg2576 and PSAPP Mouse Models of Alzheimer's Disease Are Centered on Vessel Walls
Am. J. Pathol., August 1, 2005; 167(2): 527 - 543.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. Edwards-Lee, J. M. Ringman, J. Chung, J. Werner, A. Morgan, P. St. G. Hyslop, P. Thompson, R. Dutton, A. Mlikotic, E. Rogaeva, et al.
An African American family with early-onset Alzheimer disease and an APP (T714I) mutation
Neurology, January 25, 2005; 64(2): 377 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Willem, I. Dewachter, N. Smyth, T. Van Dooren, P. Borghgraef, C. Haass, and F. Van Leuven
{beta}-Site Amyloid Precursor Protein Cleaving Enzyme 1 Increases Amyloid Deposition in Brain Parenchyma but Reduces Cerebrovascular Amyloid Angiopathy in Aging BACE x APP[V717I] Double-Transgenic Mice
Am. J. Pathol., November 1, 2004; 165(5): 1621 - 1631.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
Y Wakutani, K Watanabe, Y Adachi, K Wada-Isoe, K Urakami, H Ninomiya, T C Saido, T Hashimoto, T Iwatsubo, and K Nakashima
Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 1039 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. B. J. Kwok, G. M. Halliday, W. S. Brooks, G. Dolios, H. Laudon, O. Murayama, M. Hallupp, R. F. Badenhop, J. Vickers, R. Wang, et al.
Presenilin-1 Mutation L271V Results in Altered Exon 8 Splicing and Alzheimer's Disease with Non-cored Plaques and No Neuritic Dystrophy
J. Biol. Chem., February 21, 2003; 278(9): 6748 - 6754.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Kumar-Singh, P. Cras, R. Wang, J. M. Kros, J. van Swieten, U. Lubke, C. Ceuterick, S. Serneels, K.'l Vennekens, J.-P. Timmermans, et al.
Dense-Core Senile Plaques in the Flemish Variant of Alzheimer's Disease Are Vasocentric
Am. J. Pathol., August 1, 2002; 161(2): 507 - 520.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. C. Dimakopoulos and R. J. Mayer
Aspects of Neurodegeneration in the Canine Brain
J. Nutr., June 1, 2002; 132(6): 1579S - 1582.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Pasalar, H. Najmabadi, A. R. Noorian, B. Moghimi, A. Jannati, A. Soltanzadeh, T. Krefft, R. Crook, and J. Hardy
An Iranian family with Alzheimer's disease caused by a novel APP mutation (Thr714Ala)
Neurology, May 28, 2002; 58(10): 1574 - 1575.
[Full Text] [PDF]

Home page
 BrainHome page
B. Dermaut, S. Kumar-Singh, C. De Jonghe, M. Cruts, A. Lofgren, U. Lubke, P. Cras, R. Dom, P. P. De Deyn, J. J. Martin, et al.
Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation
Brain, December 1, 2001; 124(12): 2383 - 2392.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wiltfang, H. Esselmann, P. Cupers, M. Neumann, H. Kretzschmar, M. Beyermann, D. Schleuder, H. Jahn, E. Ruther, J. Kornhuber, et al.
Elevation of beta -Amyloid Peptide 2-42 in Sporadic and Familial Alzheimer's Disease and Its Generation in PS1 Knockout Cells
J. Biol. Chem., November 9, 2001; 276(46): 42645 - 42657.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. De Jonghe, C. Esselens, S. Kumar-Singh, K. Craessaerts, S. Serneels, F. Checler, W. Annaert, C. Van Broeckhoven, and B. De Strooper
Pathogenic APP mutations near the {gamma}-secretase cleavage site differentially affect A{beta} secretion and APP C-terminal fragment stability
Hum. Mol. Genet., August 1, 2001; 10(16): 1665 - 1671.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.